Discussion Topic:Â Class 1C Antiarrhythmics for Premature Ventricular Complex Suppression in Nonischemic Cardiomyopathy With Implantable Cardioverter-Defibrillators
William H. Sauer, MD, FHRS, CCDS, Brigham and Women’s Hospital is joined by Edward P. Gerstenfeld, MD, MS, FHRS, University of California, San Francisco, and Yasser Rodriguez, MBA, MD, Cleveland Clinic Florida to discuss premature ventricular complexes (PVCs) are common and associated with worse outcomes in patients with heart failure. Class 1C antiarrhythmic drugs (AADs) effectively suppress PVCs, but guidelines currently restrict their use in structural heart disease.
Host:Â William Sauer, MD, FHRS, CCDS
Guests:Â Edward Gerstenfeld, MD, MS, FHRS & Yasser Rodriguez, MBA, MD
Speaker and Article Information:Â Download
Topic
- The Lead
Resource Type
- Podcasts
Related Resources
The Lead
Podcasts
The Lead Episode 154: A Discussion of Safety and Effectiveness of a Dual-Energy Focal Ablation Catheter to Treat Paroxysmal Atrial Fibrillation: 6- Month Results of the FlexPulse IDE Study
June 4, 2026
EP Edge Journal Watch
Podcasts
Inaugural EP Edge Journal Watch with HRS: AVANT GUARD, LAA Closure, OCEAN, and the ALONE-AF Cognitive Substudy
May 29, 2026
The Lead
Podcasts
The Lead Episode 153: A Discussion of Exercise Capacity and Quality-of-Life Improvements after Catheter Ablation in Patients with Clinically Asymptomatic Persistent Atrial Fibrillation
May 28, 2026